miR-182 attenuates atrophy-related gene expression by targeting FoxO3 in skeletal muscle

Matthew B Hudson1, Jill A Rahnert2, Bin Zheng2

  • 1Department of Medicine, Renal Division, Emory University, Atlanta, Georgia; mbhudson@emory.edu.

Insights

MicroRNA-182 (miR-182) regulates skeletal muscle atrophy by controlling the expression of FoxO3. Decreased miR-182 is linked to muscle wasting in catabolic diseases like diabetes.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Physiology

Background:

  • Skeletal muscle atrophy is a complex process implicated in various diseases.
  • MicroRNAs (miRNAs) are emerging as key regulators in cellular processes, including muscle wasting.
  • The transcription factor FoxO3 (forkhead box O3) plays a critical role in mediating muscle atrophy by upregulating proteolytic systems.

Purpose of the Study:

  • To investigate the role of microRNAs in skeletal muscle atrophy.
  • To identify specific microRNAs that target the FoxO3 mRNA.
  • To elucidate the regulatory relationship between miR-182 and FoxO3 in the context of muscle atrophy.

Main Methods:

  • In silico analysis to predict miRNA targets.
  • Utilized C2C12 myotubes for cell culture experiments.
  • Employed immunoblot analysis, quantitative real-time RT-PCR, and luciferase reporter assays.
  • Induced muscle atrophy using dexamethasone and diabetes model in rats (streptozotocin).
  • Exosome isolation and analysis.

Main Results:

  • miR-182 was predicted to target FoxO3 mRNA and experimentally confirmed to regulate FoxO3 expression in myotubes.
  • Overexpression of miR-182 decreased FoxO3 mRNA and protein levels, and prevented the upregulation of FoxO3 target genes involved in muscle breakdown.
  • miR-182 expression was significantly reduced in dexamethasone-treated myotubes and in the muscle of diabetic rats.
  • miR-182 was found in exosomes, and its abundance increased with dexamethasone treatment.

Conclusions:

  • miR-182 is identified as a crucial regulator of FoxO3 expression in skeletal muscle.
  • This microRNA plays a significant role in controlling atrophy-related genes during catabolic conditions.
  • miR-182 represents a potential therapeutic target for mitigating skeletal muscle atrophy in diseases like diabetes.

Related Concept Videos

Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.8K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.0K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.7K